Published in Antimicrob Agents Chemother on April 01, 1983
Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 3.87
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob Agents Chemother (1993) 2.35
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother (1984) 1.77
Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J Clin Microbiol (1988) 1.63
Identification of a circular intermediate in the transfer and transposition of Tn4555, a mobilizable transposon from Bacteroides spp. J Bacteriol (1993) 1.58
Differentiation of Bacteroides ovatus and Bacteroides thetaiotaomicron by means of bacteriophage. J Clin Microbiol (1984) 1.51
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother (1984) 1.35
Comparative activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.35
Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase. Antimicrob Agents Chemother (1990) 1.25
Susceptibility testing of anaerobic bacteria: myth, magic, or method? Clin Microbiol Rev (1991) 1.25
Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 1.24
Imipenem versus moxalactam in the treatment of serious infections. Antimicrob Agents Chemother (1983) 1.22
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15
Analysis of rRNA restriction fragment length polymorphisms from Bacteroides spp. and Bacteroides fragilis isolates associated with diarrhea in humans and animals. J Clin Microbiol (1992) 1.12
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother (1990) 1.04
Antimicrobial activity of HR810 against 419 strict anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.03
Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species. Antimicrob Agents Chemother (1988) 1.02
In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data. J Clin Microbiol (2002) 0.93
Evaluation of antibiotic therapy following penetrating abdominal trauma. Ann Surg (1985) 0.91
Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem. J Clin Microbiol (1985) 0.89
Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil. Antimicrob Agents Chemother (1987) 0.89
Activity of cefmetazole against anaerobic bacteria. Antimicrob Agents Chemother (1987) 0.89
Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum. J Clin Microbiol (1985) 0.86
In vitro activity of cefbuperazone against Bacteroides spp. Antimicrob Agents Chemother (1985) 0.85
Impact of antimicrobial agents and chemotherapy from 1972 to 1998. Antimicrob Agents Chemother (2000) 0.80
Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics. Antimicrob Agents Chemother (1990) 0.80
Common bacterial pathogens and resistance to antibiotics. Br Med J (Clin Res Ed) (1984) 0.75
Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood. Antimicrob Agents Chemother (1989) 0.75
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1985) 0.75
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
The susceptibility of Bacteroides fragilis to 24 antibiotics. J Infect Dis (1972) 6.12
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother (1981) 2.96
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Mechanisms of drug-resistance transfer in Bacteroides fragilis. J Antimicrob Chemother (1981) 2.46
Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrob Agents Chemother (1978) 2.45
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. Rev Infect Dis (1981) 2.38
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother (1977) 1.67
Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother (1978) 1.66
Transposon-like structures in the Bacteroides fragilis MLS plasmid plP 410. Mol Gen Genet (1981) 1.42
Experimental animal models for anaerobic infections. Rev Infect Dis (1980) 1.38
A survey of Bacteroides susceptibility in the United States. J Antimicrob Chemother (1981) 1.29
Chloramphenicol acetyltransferase of Bacteroides fragilis. Antimicrob Agents Chemother (1978) 1.13
Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance. Antimicrob Agents Chemother (1981) 1.10
Antibiotic sensitivity of anaerobic bacteria. Ann Ist Super Sanita (1979) 0.92
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Rapid diagnosis of bacteremia. Appl Microbiol (1969) 11.82
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med (1992) 8.67
Anaerobic infections. 1. N Engl J Med (1974) 8.02
Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol (1971) 6.99
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol (1972) 6.17
Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. Appl Microbiol (1972) 6.04
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. JAMA (1966) 5.66
Toxigenic Escherichia coli: a cause of infantile diarrhea in Chicago. N Engl J Med (1972) 5.45
Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother (1990) 5.24
Treating diarrhoea. BMJ (1997) 5.22
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Practical aerobic membrane filtration blood culture technique: clinical blood culture trial. J Clin Microbiol (1975) 4.80
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis (1972) 4.62
Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr (1974) 4.58
In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother (1999) 4.44
Legionnaires' disease: clinical features of 24 cases. Ann Intern Med (1978) 4.30
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis (1975) 4.16
Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1976) 4.07
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90
Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 3.87
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. J Clin Microbiol (1979) 3.86
Intestinal microflora. Gastroenterology (1971) 3.86
Intestinal flora in health and disease. Gastroenterology (1984) 3.84
Evaluation of polyanethol sulfonate (liquoid) in blood cultures. Antimicrob Agents Chemother (Bethesda) (1967) 3.80
Comparison of three procedures for biochemical testing of anaerobic bacteria. J Clin Microbiol (1975) 3.75
Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol (1994) 3.74
Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology (1967) 3.71
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62
Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology (1967) 3.60
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med (1992) 3.59
Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother (1973) 3.47
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. Appl Microbiol (1973) 3.30
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Antibiotics and sacred cows. J Can Dent Assoc (1999) 3.29
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet (1973) 3.18
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Studies of drugs given before anaesthesia. XV. Evaluation of the method of study after 10,000 observations. Br J Anaesth (1968) 3.14
Anaerobic infections (third of three parts). N Engl J Med (1974) 3.13
Bacteroides fragilis resistant to the administration of clindamycin. Am J Med (1976) 3.13
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother (1993) 3.13
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
Cohort mortality from carcinoma of the cervix. Lancet (1967) 3.08
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Studies on enterotoxin from Escherichia coli associated with acute diarrhea in man. J Lab Clin Med (1971) 3.03
Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) (1980) 2.81
Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. J Bacteriol (1982) 2.80
Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I. Antimicrob Agents Chemother (1978) 2.79
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Oxygen tolerance of fresh clinical anaerobic bacteria. J Clin Microbiol (1975) 2.77
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76
Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
In vitro activity of azthreonam, a monobactam antibiotic. Antimicrob Agents Chemother (1982) 2.70
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66